Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-04-11

Clinical Trial Update: Polidocanol Foam in Hemorrhoidal Disease in Patients With Liver Cirrhosis [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update for polidocanol foam in hemorrhoidal disease in patients with liver cirrhosis, spanning Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Polidocanol foam (polidocanol)

Snippet

Sponsor: Universidade do Porto | Conditions: Hemorrhoids, Liver Cirrhosis | Phase 2, Phase 3 | Status: UNKNOWN